GitLab (GTLB): Evaluating the Stock’s Value After Strong Earnings, CFO Exit, and Cautious Guidance

If you are following GitLab (GTLB), this past week probably had you double-checking your portfolio. The company delivered impressive second-quarter results, with revenue jumping 29% year-over-year and earnings comfortably ahead of estimates. However, within hours of announcing these numbers, GitLab revealed that CFO Brian Robins is stepping down. This move, combined with their cautious revenue outlook for the next quarter, sent the stock down sharply and rattled investor confidence.

It is an interesting twist for a company that has managed to post consistent growth even as competitive pressures in software development intensify. So far this year, GitLab shares are down 19% and trailing last year’s performance as well. Market momentum has faded: the stock gave up 6% in the past three months, even though it surged 13% over the last month before these latest announcements. Leadership turnover, paired with signals of slowing revenue growth, are clearly weighing on how investors price GitLab’s long-term potential.

After this run of volatility, is GitLab a bargain for growth-focused investors, or are markets already pricing in everything management hopes to deliver?

Advertisement

Most Popular Narrative: 26% Undervalued

The most widely followed narrative suggests GitLab shares are undervalued by more than a quarter. This view hinges on forecasts of strong revenue growth, emerging AI integrations, and assumptions about future profitability levels eventually reaching industry standards.

GitLab's expansion of AI-driven capabilities across its DevSecOps platform, including the upcoming Duo Agent Platform with hybrid usage-based monetization, is expected to capture increased demand for automation and developer productivity tools. This could accelerate revenue growth and expand margins as high-value features command premium pricing and upsell opportunities.

Curious about why analysts think GitLab could be trading far below its true potential? The narrative’s bullish view leans on a bold vision of future growth and profit margins that rival the sector’s biggest names. Wondering which performance milestones and market shifts could make or break these high expectations? Discover the projections that have Wall Street buzzing.

Result: Fair Value of $61.81 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, intensifying competition and execution risks related to leadership changes could easily disrupt GitLab's optimistic growth outlook and threaten long-term margin improvement.

Find out about the key risks to this GitLab narrative.

Another Perspective: Market-Based View

Looking through the lens of market pricing, GitLab’s valuation appears high compared to the broader software sector. This approach questions how much future profit is already built into today’s share price, which sparks debate among investors.

See what the numbers say about this price — find out in our valuation breakdown.
NasdaqGS:GTLB PS Ratio as at Sep 2025
NasdaqGS:GTLB PS Ratio as at Sep 2025
Stay updated when valuation signals shift by adding GitLab to your watchlist or portfolio. Alternatively, explore our screener to discover other companies that fit your criteria.

Build Your Own GitLab Narrative

If these perspectives do not align with your own, or you want to investigate the numbers firsthand, you can easily craft your own analysis of GitLab in just minutes. Do it your way.

A great starting point for your GitLab research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.

Looking for More Smart Investment Ideas?

Now is the perfect time to broaden your portfolio with handpicked stock ideas. Let the Simply Wall Street Screener help you spot untapped potential and keep you ahead of the crowd.

  • Uncover value gems trading below their true worth by checking out undervalued stocks based on cash flows. These options could strengthen your holdings.
  • Spot companies that are shaking up artificial intelligence and positioning themselves at the forefront of tomorrow’s tech by browsing AI penny stocks.
  • Access opportunities among rising stars with both affordable stock prices and robust financials inside penny stocks with strong financials, so you never miss the next breakout.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Kshitija Bhandaru

Kshitija Bhandaru

Kshitija (or Keisha) Bhandaru is an Equity Analyst at Simply Wall St and has over 6 years of experience in the finance industry and describes herself as a lifelong learner driven by her intellectual curiosity. She previously worked with Market Realist for 5 years as an Equity Analyst.

About NasdaqGS:GTLB

GitLab

Develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific.

Flawless balance sheet and fair value.

Advertisement

Weekly Picks

CE
Ceazar
SPAI.F logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:US$3.8756.1% undervalued
17 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4859.0% undervalued
212 users have followed this narrative
8 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43047.7% undervalued
19 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9953.6% undervalued
25 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

HE
NGXGROUP logo
Henrynuke03 on Nigerian Exchange Group ·

Future Growth Awaits NGXGROUP with New High-Profile Listings

Fair Value:₦221.1732.3% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PR
PrashhD
AURIONPRO logo
PrashhD on Aurionpro Solutions ·

Aurionpro Solutions: Is the Market Mispricing One of India's Most Interesting Fintech Product Companies?

Fair Value:₹1k27.1% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
NE
LOT logo
newsfinder11221 on Lotus Technology ·

Lotus Technology: A Technology-Driven Luxury EV Brand with a Promising Turnaround Story

Fair Value:US$2.464.0% undervalued
1 users have followed this narrative
2 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28032.1% undervalued
211 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.0% undervalued
97 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.2% undervalued
74 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0